• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国结直肠癌患者的基因组和转录组分析。

Genomic and transcriptomic analysis of Korean colorectal cancer patients.

机构信息

Personalized Genomic Medicine Research Center, Daejeon, South Korea.

Korea Bioinformation Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, South Korea.

出版信息

Genes Genomics. 2022 Aug;44(8):967-979. doi: 10.1007/s13258-022-01275-4. Epub 2022 Jun 25.

DOI:10.1007/s13258-022-01275-4
PMID:35751785
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9273532/
Abstract

BACKGROUND

Colorectal cancer (CRC) is the third most common type of diagnosed cancer in the world and has the second-highest mortality rate. Meanwhile, South Korea has the second-highest incidence rate for CRC in the world.

OBJECTIVE

To assess the possible influence of ethnicity on the molecular profile of colorectal cancer, we compared genomic and transcriptomic features of South Korean CRCs with European CRCs.

METHODS

We assembled a genomic and transcriptomic dataset of South Korean CRC patients (KOCRC; n = 126) from previous studies and European cases (EUCRC; n = 245) selected from The Cancer Genome Atlas (TCGA). Then, we compared the two datasets in terms of clinical data, driver genes, mutational signature, gene sets, consensus molecular subtype, and fusion genes.

RESULTS

These two cohorts showed similar profiles in driver mutations but differences in the mutation frequencies of some driver genes (including APC, TP53, PABPC1, FAT4, MUC7, HSPG2, GNAS, DENND5B, and BRAF). Analysis of hallmark pathways using genomic data sets revealed further differences between these populations in the WNT, TP53, and NOTCH signaling pathways. In consensus molecular subtype (CMS) analyses of the study cases, no BRAF mutations were found in the CMS1 subtype of KOCRC, which contrasts with previous findings. Fusion gene analysis identified oncogenic fusion of PTPRK-RSPO3 in a subset of KOCRC patients without APC mutations.

CONCLUSIONS

This study presents insights into the genomic landscape of KOCRCs and reveals some similarities and differences with EUCRCs at the molecular level.

摘要

背景

结直肠癌(CRC)是世界上第三大常见的癌症类型,死亡率居第二位。同时,韩国是世界上 CRC 发病率第二高的国家。

目的

为了评估种族差异对结直肠癌分子谱的可能影响,我们比较了韩国 CRC 与欧洲 CRC 的基因组和转录组特征。

方法

我们从之前的研究中收集了韩国 CRC 患者(KOCRC;n=126)的基因组和转录组数据集,并从癌症基因组图谱(TCGA)中选择了欧洲病例(EUCRC;n=245)。然后,我们比较了这两个数据集在临床数据、驱动基因、突变特征、基因集、共识分子亚型和融合基因方面的差异。

结果

这两个队列在驱动突变方面表现出相似的特征,但在一些驱动基因的突变频率上存在差异(包括 APC、TP53、PABPC1、FAT4、MUC7、HSPG2、GNAS、DENND5B 和 BRAF)。使用基因组数据集分析标志性通路显示,这两个群体在 WNT、TP53 和 NOTCH 信号通路方面存在进一步的差异。在研究病例的共识分子亚型(CMS)分析中,KOCRC 的 CMS1 亚型中未发现 BRAF 突变,这与之前的发现相反。融合基因分析发现 KOCRC 患者中存在 PTPRK-RSPO3 的致癌融合,而这些患者中没有 APC 突变。

结论

本研究揭示了 KOCRC 的基因组景观,并在分子水平上揭示了与 EUCRC 的一些相似和不同之处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7e6/9273532/570f9c804a02/13258_2022_1275_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7e6/9273532/37626c386e2c/13258_2022_1275_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7e6/9273532/8e11f6fb452c/13258_2022_1275_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7e6/9273532/84c8a876831a/13258_2022_1275_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7e6/9273532/ebe9d75fc3b2/13258_2022_1275_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7e6/9273532/d48e2f6f48d7/13258_2022_1275_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7e6/9273532/570f9c804a02/13258_2022_1275_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7e6/9273532/37626c386e2c/13258_2022_1275_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7e6/9273532/8e11f6fb452c/13258_2022_1275_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7e6/9273532/84c8a876831a/13258_2022_1275_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7e6/9273532/ebe9d75fc3b2/13258_2022_1275_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7e6/9273532/d48e2f6f48d7/13258_2022_1275_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7e6/9273532/570f9c804a02/13258_2022_1275_Fig6_HTML.jpg

相似文献

1
Genomic and transcriptomic analysis of Korean colorectal cancer patients.韩国结直肠癌患者的基因组和转录组分析。
Genes Genomics. 2022 Aug;44(8):967-979. doi: 10.1007/s13258-022-01275-4. Epub 2022 Jun 25.
2
Genomic and transcriptomic characterization of heterogeneous immune subgroups of microsatellite instability-high colorectal cancers.微卫星不稳定高结直肠癌异质性免疫亚群的基因组和转录组特征。
J Immunother Cancer. 2021 Dec;9(12). doi: 10.1136/jitc-2021-003414.
3
Genomic landscape of colorectal cancer in Japan: clinical implications of comprehensive genomic sequencing for precision medicine.日本结直肠癌的基因组图谱:精准医学中全面基因组测序的临床意义
Genome Med. 2016 Dec 22;8(1):136. doi: 10.1186/s13073-016-0387-8.
4
Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles.早期结直肠癌类器官培养物揭示了独特且罕见的遗传特征。
Gut. 2020 Dec;69(12):2165-2179. doi: 10.1136/gutjnl-2019-320019. Epub 2020 Mar 26.
5
RSPO fusion transcripts in colorectal cancer in Japanese population.日本人群结直肠癌中的RSPO融合转录本
Mol Biol Rep. 2014 Aug;41(8):5375-84. doi: 10.1007/s11033-014-3409-x. Epub 2014 May 22.
6
Consensus molecular subtype classification of colorectal adenomas.结直肠腺瘤的共识分子亚型分类。
J Pathol. 2018 Nov;246(3):266-276. doi: 10.1002/path.5129. Epub 2018 Aug 31.
7
Genomic Alterations of NTRK, POLE, ERBB2, and Microsatellite Instability Status in Chinese Patients with Colorectal Cancer.中国结直肠癌患者的 NTRK、POLE、ERBB2 基因改变和微卫星不稳定性状态。
Oncologist. 2020 Nov;25(11):e1671-e1680. doi: 10.1634/theoncologist.2020-0356. Epub 2020 Aug 10.
8
CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer.CMS 依赖性 KRAS 和 BRAFV600E 突变对原发性结直肠癌的预后影响。
Ann Oncol. 2018 May 1;29(5):1227-1234. doi: 10.1093/annonc/mdy085.
9
Comprehensive genomic profiling reveals prognostic signatures and insights into the molecular landscape of colorectal cancer.全面基因组分析揭示了结直肠癌的预后特征及对分子格局的见解。
Front Oncol. 2023 Nov 13;13:1285508. doi: 10.3389/fonc.2023.1285508. eCollection 2023.
10
The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal Cancer.共识分子亚型的演变角色:超越住院患者选择治疗结直肠癌的一步。
Curr Treat Options Oncol. 2021 Nov 6;22(12):113. doi: 10.1007/s11864-021-00913-5.

引用本文的文献

1
Contract to kill: GNAS mutation.致命契约:GNAS 突变
Mol Cancer. 2025 Mar 7;24(1):70. doi: 10.1186/s12943-025-02247-4.
2
High Probability of Lynch Syndrome Among Colorectal Cancer Patients Is Associated With Higher Occurrence of KRAS and PIK3CA Mutations.结直肠癌患者中林奇综合征的高概率与KRAS和PIK3CA突变的更高发生率相关。
World J Oncol. 2024 Aug;15(4):612-624. doi: 10.14740/wjon1843. Epub 2024 Jun 17.
3
Identification of cuproptosis-related miRNAs in triple-negative breast cancer and analysis of the miRNA-mRNA regulatory network.

本文引用的文献

1
Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis.共识分子亚型在结直肠癌中的临床价值:系统评价和荟萃分析。
J Natl Cancer Inst. 2022 Apr 11;114(4):503-516. doi: 10.1093/jnci/djab106.
2
Role of POLE and POLD1 in familial cancer.POLE 和 POLD1 在家族性癌症中的作用。
Genet Med. 2020 Dec;22(12):2089-2100. doi: 10.1038/s41436-020-0922-2. Epub 2020 Aug 14.
3
A compendium of mutational cancer driver genes.癌症驱动基因突变综合分析
三阴性乳腺癌中铜死亡相关miRNA的鉴定及miRNA-mRNA调控网络分析
Heliyon. 2024 Mar 27;10(7):e28242. doi: 10.1016/j.heliyon.2024.e28242. eCollection 2024 Apr 15.
4
Exploring the DNA methylome of Korean patients with colorectal cancer consolidates the clinical implications of cancer-associated methylation markers.探讨韩国结直肠癌患者的 DNA 甲基化组学,可明确癌症相关甲基化标志物的临床意义。
BMB Rep. 2024 Mar;57(3):161-166. doi: 10.5483/BMBRep.2023-0103.
5
Detection of germline variants with pathogenic potential in 48 patients with familial colorectal cancer by using whole exome sequencing.采用全外显子组测序技术在 48 例家族性结直肠癌患者中检测具有潜在致病性的种系变异。
BMC Med Genomics. 2023 Jun 9;16(1):126. doi: 10.1186/s12920-023-01562-3.
Nat Rev Cancer. 2020 Oct;20(10):555-572. doi: 10.1038/s41568-020-0290-x. Epub 2020 Aug 10.
4
Comprehensive characterization of driver genes in diffuse large B cell lymphoma.弥漫性大B细胞淋巴瘤中驱动基因的综合特征分析。
Oncol Lett. 2020 Jul;20(1):382-390. doi: 10.3892/ol.2020.11552. Epub 2020 Apr 21.
5
The Evolving AML Genomic Landscape: Therapeutic Implications.急性髓细胞白血病(AML)基因组图谱的演变:治疗意义。
Curr Cancer Drug Targets. 2020;20(7):532-544. doi: 10.2174/1568009620666200424150321.
6
Comprehensive review of targeted therapy for colorectal cancer.结直肠癌靶向治疗的综合综述。
Signal Transduct Target Ther. 2020 Mar 20;5(1):22. doi: 10.1038/s41392-020-0116-z.
7
A prognostic index based on an eleven gene signature to predict systemic recurrences in colorectal cancer.基于十一基因特征的预后指数预测结直肠癌的全身复发。
Exp Mol Med. 2019 Oct 2;51(10):1-12. doi: 10.1038/s12276-019-0319-y.
8
Large-Scale Genome-Wide Association Study of East Asians Identifies Loci Associated With Risk for Colorectal Cancer.大规模东亚人群全基因组关联研究鉴定结直肠癌风险相关位点。
Gastroenterology. 2019 Apr;156(5):1455-1466. doi: 10.1053/j.gastro.2018.11.066. Epub 2018 Dec 6.
9
COSMIC: the Catalogue Of Somatic Mutations In Cancer.COSMIC:癌症体细胞突变目录。
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947. doi: 10.1093/nar/gky1015.
10
Maftools: efficient and comprehensive analysis of somatic variants in cancer.Maftools:癌症体细胞变异的高效全面分析。
Genome Res. 2018 Nov;28(11):1747-1756. doi: 10.1101/gr.239244.118. Epub 2018 Oct 19.